Literature DB >> 2867001

Beta-adrenergic control of motility in the rat colon. I. Evidence for functional separation of the beta 1- and beta 2-adrenoceptor-mediated inhibition of colon activity.

B A Ek, L A Bjellin, B T Lundgren.   

Abstract

The beta-adrenoceptor-mediated inhibitory response in isolated rat colon strips of beta-adrenoceptor agonists (isoproterenol, terbutaline, prenalterol) in the absence and presence of the selective beta-adrenoceptor antagonists metoprolol (beta 1) and IPS 339 (beta 2) demonstrates that both beta 1- and beta 2-adrenoceptors are involved in the inhibition of colonic motility. Neuronal blockade induced by tetrodotoxin suppressed the relatively high (68%) maximal response of prenalterol (partial beta-adrenoceptor agonist) to 23%. The concentration-response curves for terbutaline (beta 2-selective agonist) and isoproterenol (nonselective agonist) were not influenced by tetrodotoxin. The results thus indicate that the beta-adrenergic inhibition of spontaneous activity in the rat colon strip may be mediated at two functional levels within the colon wall: either by beta 2-adrenoceptors in the smooth muscle layer or by beta 1-adrenoceptors in the intramural ganglionic plexuses, which by neuronal elements are coupled to the effector smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2867001     DOI: 10.1016/0016-5085(86)90939-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Stimulation of beta-adrenoceptors with isoprenaline inhibits small intestinal activity fronts and induces a postprandial-like motility pattern in humans.

Authors:  M Thollander; T H Svensson; P M Hellström
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical beta-adrenoceptors in rat colon.

Authors:  A Bianchetti; L Manara
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

3.  Single doses of ritodrine delay orocaecal transit in patients with irritable bowel syndrome.

Authors:  G Basilisco; M G Camboni; A Bozzani; M Molgora; P A Bianchi
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

4.  Muscarinic receptor interaction with full and partial beta-adrenoceptor agonists in the rat colon strip.

Authors:  B Ek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

5.  Laser Doppler measurement of rectal mucosal blood flow.

Authors:  A V Emmanuel; M A Kamm
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

6.  Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P.

Authors:  F Guagnini; M Valenti; S Mukenge; I Matias; A Bianchetti; S Di Palo; G Ferla; V Di Marzo; T Croci
Journal:  Gut       Date:  2006-01-19       Impact factor: 23.059

Review 7.  Rational pharmacotherapy of gastrointestinal motility disorders.

Authors:  P Demol; H J Ruoff; T R Weihrauch
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

8.  Abnormalities of innervation of internal anal sphincter in fecal incontinence.

Authors:  C T Speakman; C H Hoyle; M M Kamm; M M Henry; R J Nicholls; G Burnstock
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.